miR-210 regulates glioma cell proliferation by targeting FGFRL 1, and under hypoxic conditions, it establishes a positive feedback loop that enhances HIF-1a stability by suppressing GPD1L, leading to the induction of genes associated with energy metabolism, angiogenesis, cell proliferation, and survival.10 This evidence concerns the gene GPD1L and central nervous system cancer.